TESSA THERAPEUTICS LTD.
Last Updated: 13 Apr 2026
Tessa Therapeutics is a clinical-stage biotechnology company focused on developing autologous and allogenic cell therapies for various cancers using cutting-edge technologies such as CD30-Chimeric Antigen Receptors (CD30-CARs) and Virus-Specific T Cells (VSTs). Our goal is to revolutionize cancer treatment and improve patient lives by bringing innovative therapies to market faster through our state-of-the-art GMP cell therapy manufacturing facility set to launch in 2021. At Tessa, we prioritize patient care and are committed to creating a new lease on life for those affected by cancer.
Country of registration | Singapore |
Registration number | 201120185N |
Local SIC | |
Incorporation date | 26 Aug 2011 |
Company age | 14 years 9 months |
Official entity type | Public Company Limited By Shares |
No. of officers | 149 |
Contact
Address:
12 MARINA VIEW, #15-01, ASIA SQUARE TOWER 2, Singapore 018961
Phone number:
Access Key Decision Makers
This is the legal entity page of TESSA THERAPEUTICS LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- TESSA THERAPEUTICS LTDView MoreSingaporeTessa Therapeutics is a clinical-stage biotechnology company focused on developing autologous and allogenic cell therapies for various cancers using cutting-edge technologies such as CD30-Chimeric Antigen Receptors (CD30-CARs) and Virus-Specific T Cells (VSTs). Our goal is to revolutionize cancer treatment and improve patient lives by bringing innovative therapies to market faster through our state-of-the-art GMP cell therapy manufacturing facility set to launch in 2021. At Tessa, we prioritize patient care and are committed to creating a new lease on life for those affected by cancer.
This is the legal entity page of TESSA THERAPEUTICS LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Auditor | PRICEWATERHOUSECOOPERS LLP |
Revenue | > 10m |
Share Capital - Ordinary shares | SGD 8,570,836 |
Share Capital - Preference shares | USD 126,665,743 |
Share Capital - Ordinary shares | USD 264,000,281 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of TESSA THERAPEUTICS LTD.?
- Where is TESSA THERAPEUTICS LTD.'s headquarter?
- What is TESSA THERAPEUTICS LTD.'s contact number?
- What TESSA THERAPEUTICS LTD.'s spending power?
- Does TESSA THERAPEUTICS LTD. have a presence in the domain it operates in?